Price
No data yet.
Social Signal Score
Company Profile
- Sector
- Financial Services
- Industry
- Asset Management
- Beta
- 0.76
- Country
- US
Quote
Valuation & Ratios
Returns & Efficiency
Valuation
FBThas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Signal Score (90d)
155+210.00%Social Signal Score
Mentions (6)
- Newsfool.com·8d ago·Positive
Better Biotech ETF: First Trust's FBT vs. Invesco's PBE The First Trust NYSE Arca Biotechnology Index Fund has a lower expense ratio and significantly higher assets under management (AUM). The First Trust NYSE Arca Biotechnology Index Fund outperformed the Invesco fund on a 1-year total return basis and over a five-year period.
View source ↗ - Newsfool.com·8d ago·Negative
Two Ways to Play Biotech: FBT's Return Edge vs. IBB's Cost Advantage First Trust NYSE Arca Biotechnology Index Fund maintains a more concentrated portfolio of 30 holdings compared to the 243 positions found in iShares Biotechnology ETF. iShares Biotechnology ETF carries a lower expense ratio of 0.44% whereas First Trust NYSE Arca Biotechnology Index Fund charges 0.55%.
View source ↗ - Newszacks.com·18d ago·Neutral
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? Looking for broad exposure to the Healthcare - Biotech segment of the equity market? You should consider the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed exchange traded fund launched on June 19, 2006.
View source ↗ - Newsfool.com·43d ago·Neutral
Better Biotechnology ETF: First Trust FBT vs. VanEck BBH The First Trust NYSE Arca Biotechnology Index Fund has outperformed the VanEck Biotech ETF on a one-year basis and over the last five years. The VanEck Biotech ETF offers a lower expense ratio of 0.35% compared to 0.55% for the First Trust fund.
View source ↗ - Newszacks.com·72d ago·Positive
Is First Trust NYSE Arca Biotechnology ETF (FBT) a Strong ETF Right Now? A smart beta exchange traded fund, the First Trust NYSE Arca Biotechnology ETF (FBT) debuted on 06/19/2006, and offers broad exposure to the Health Care ETFs category of the market.
View source ↗ - Newszacks.com·82d ago·Neutral
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? Launched on June 19, 2006, the First Trust NYSE Arca Biotechnology ETF (FBT) is a passively managed exchange traded fund designed to provide a broad exposure to the Healthcare - Biotech segment of the equity market.
View source ↗
Congress trades
No disclosed congressional trades in FBT.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
